Shenzhen Mindray Bio-Medical Electronics revenue and financials
¥161.32Change from previous close: +1.45%Absolute change: +¥2.31
In the fiscal year ended December 2025, Shenzhen Mindray Bio-Medical Electronics reported revenue of ¥33.28B (−9.38% year over year). Net income was ¥8.14B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −9.38%
- 2025 vs 2024
- Net income growth
- −30.28%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 31.8%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 10,145 | 12,432 | 11,062 | 12,141 | — |
| Depreciation and amortization | 1,721 | 1,469 | 1,010 | 885 | — |
| Capital expenditure | -2,038 | -1,959 | -2,689 | -1,916 | — |
| Investing cash flow | -509 | -7,383 | -693 | -3,220 | — |
| Financing cash flow | -6,724 | -8,882 | -10,776 | -5,194 | — |
| Dividends paid | -5,615 | -8,743 | -10,670 | -4,233 | — |
| Debt issued | 4.7 | 2.6 | — | — | — |
| Debt repaid | -7.3 | -5.5 | -18.8 | — | -441 |
| Effect of exchange rates | -195 | 72.2 | 101 | 114 | — |
| Net change in cash | 2,912 | -3,833 | -407 | 3,727 | — |
| Free cash flow | 8,107 | 10,473 | 8,373 | 10,226 | — |